243 related articles for article (PubMed ID: 22481966)
1. Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy.
de Carvalho F; Vettore AL; Colleoni GW
Clin Dev Immunol; 2012; 2012():257695. PubMed ID: 22481966
[TBL] [Abstract][Full Text] [Related]
2. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
Jungbluth AA; Ely S; DiLiberto M; Niesvizky R; Williamson B; Frosina D; Chen YT; Bhardwaj N; Chen-Kiang S; Old LJ; Cho HJ
Blood; 2005 Jul; 106(1):167-74. PubMed ID: 15761016
[TBL] [Abstract][Full Text] [Related]
3. Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.
de Carvalho F; Costa ET; Camargo AA; Gregorio JC; Masotti C; Andrade VC; Strauss BE; Caballero OL; Atanackovic D; Colleoni GW
PLoS One; 2011; 6(11):e27707. PubMed ID: 22110734
[TBL] [Abstract][Full Text] [Related]
4. MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.
de Carvalho F; Alves VL; Braga WM; Xavier CV; Colleoni GW
Cancer Immunol Immunother; 2013 Jan; 62(1):191-5. PubMed ID: 23180015
[TBL] [Abstract][Full Text] [Related]
5. Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.
Atanackovic D; Hildebrandt Y; Jadczak A; Cao Y; Luetkens T; Meyer S; Kobold S; Bartels K; Pabst C; Lajmi N; Gordic M; Stahl T; Zander AR; Bokemeyer C; Kröger N
Haematologica; 2010 May; 95(5):785-93. PubMed ID: 20015885
[TBL] [Abstract][Full Text] [Related]
6. Is there any relationship between gene expression of tumor antigens and CD4+ T cells in multiple myeloma?
Braga WM; da Silva BR; Alves VL; Bortoluzo AB; Atanackovic D; Colleoni GW
Immunotherapy; 2014; 6(5):569-75. PubMed ID: 24896625
[TBL] [Abstract][Full Text] [Related]
7. Expression of cancer-testis antigen in multiple myeloma.
He L; Ji JN; Liu SQ; Xue E; Liang Q; Ma Z
J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):181-185. PubMed ID: 24710929
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.
Lendvai N; Gnjatic S; Ritter E; Mangone M; Austin W; Reyner K; Jayabalan D; Niesvizky R; Jagannath S; Bhardwaj N; Chen-Kiang S; Old LJ; Cho HJ
Cancer Immun; 2010 Jan; 10():4. PubMed ID: 20108890
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.
Pabst C; Zustin J; Jacobsen F; Luetkens T; Kröger N; Schilling G; Bokemeyer C; Sauter G; Atanackovic D; Marx A
Exp Mol Pathol; 2010 Oct; 89(2):175-81. PubMed ID: 20621094
[TBL] [Abstract][Full Text] [Related]
10. Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence.
Perez D; Herrmann T; Jungbluth AA; Samartzis P; Spagnoli G; Demartines N; Clavien PA; Marino S; Seifert B; Jaeger D
Int J Cancer; 2008 Oct; 123(7):1551-5. PubMed ID: 18646188
[TBL] [Abstract][Full Text] [Related]
11. The role of Cancer/Testis Antigens in Multiple Myeloma pathogenesis and their application in disease monitoring and therapy.
Shires K; Van Wyk T
Crit Rev Oncol Hematol; 2018 Dec; 132():17-26. PubMed ID: 30447924
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
Atanackovic D; Luetkens T; Hildebrandt Y; Arfsten J; Bartels K; Horn C; Stahl T; Cao Y; Zander AR; Bokemeyer C; Kröger N
Clin Cancer Res; 2009 Feb; 15(4):1343-52. PubMed ID: 19190130
[TBL] [Abstract][Full Text] [Related]
13. MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.
Curioni-Fontecedro A; Knights AJ; Tinguely M; Nuber N; Schneider C; Thomson CW; von Boehmer L; Bossart W; Pahlich S; Gehring H; Moch H; Renner C; Knuth A; Zippelius A
Leukemia; 2008 Aug; 22(8):1646-8. PubMed ID: 18323799
[No Abstract] [Full Text] [Related]
14. Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.
Inaoka RJ; Jungbluth AA; Gnjatic S; Ritter E; Hanson NC; Frosina D; Tassello J; Etto LY; Bortoluzzo AB; Alves AC; Colleoni GW
Cancer Immunol Immunother; 2012 Dec; 61(12):2207-14. PubMed ID: 22638551
[TBL] [Abstract][Full Text] [Related]
15. Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.
Anderson LD; Cook DR; Yamamoto TN; Berger C; Maloney DG; Riddell SR
Cancer Immunol Immunother; 2011 Jul; 60(7):985-97. PubMed ID: 21461886
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.
Moreno-Bost A; Szmania S; Stone K; Garg T; Hoerring A; Szymonifka J; Shaughnessy J; Barlogie B; Prentice HG; van Rhee F
Cytotherapy; 2011 May; 13(5):618-28. PubMed ID: 21171821
[TBL] [Abstract][Full Text] [Related]
18. Cancer-testis antigen expression and immunogenicity in AL amyloidosis.
Rosenzweig MA; Landau H; Seldin D; O'Hara C; Girnius S; Hanson N; Frosina D; Sedrak C; Arcila M; Comenzo RL; Giralt S; Gnjatic S; Jungbluth AA; Koehne G
Blood Cancer J; 2012 Sep; 2(9):e90. PubMed ID: 22983433
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.
Wu Y; Sang M; Liu F; Zhang J; Li W; Li Z; Gu L; Zheng Y; Li J; Shan B
Carcinogenesis; 2020 Jul; 41(7):894-903. PubMed ID: 32529260
[TBL] [Abstract][Full Text] [Related]
20. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
